DR. HAGOP KANTARJIAN, MD

Dr. Kantarjian is currently serving as Professor of Medicine and Chairman of the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas, where he has been since joining as a fellow in the Department of Developmental Therapeutics in 1981. Dr. Kantarjian specializes in leukemia and holds an interest in creating new treatment approaches for these diseases. Dr. Kantarjian has authored and contributed to over 560 medical publications, articles and abstracts and, for his accomplishments, has received awards, including a Leukemia Society of America Scholarship from 1989-1994 and a Leukemia Society of America Special Fellow Scholarship from 1982-1983.

Dr. Howard Burris, MD

Dr. Howard (Skip) Burris, III is currently serving as Director of Drug Development at The Sarah Cannon Cancer Center in Nashville, Tennessee, where he is also an Associate with Tennessee Oncology, PLLC. Dr. Burris received his medical degree from the University of South Alabama in 1985, and then performed his residency and fellowship in hematology/oncology at Brook Army Medical Center in San Antonio, Texas. While there he served as Director of Clinical Research at the Institute for Drug Development and was an Associate Professor at the University of Texas Health Science Center.